Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: taltz
Psoriasis is a common skin disease with a global prevalence of 2-3%, and affects over 40,000 people in Singapore. The…
The IXORA trial is a head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis. Watch the video…
Subscribe to Updates
Subscribe to receive latest health related news from us
Copyright © Medical Channel Asia 2024.
All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.